Growth Metrics

Eton Pharmaceuticals (ETON) Depreciation and Depletion (2018 - 2025)

Eton Pharmaceuticals' Depreciation and Depletion history spans 7 years, with the latest figure at $17000.0 for Q4 2025.

  • On a quarterly basis, Depreciation and Depletion fell 55.26% to $17000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $41000.0, a 46.05% decrease, with the full-year FY2025 number at $41000.0, down 18.0% from a year prior.
  • Depreciation and Depletion hit $17000.0 in Q4 2025 for Eton Pharmaceuticals, up from $8000.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for ETON hit a ceiling of $84000.0 in Q1 2021 and a floor of $4000.0 in Q2 2025.
  • Historically, Depreciation and Depletion has averaged $19100.0 across 5 years, with a median of $13500.0 in 2022.
  • Biggest five-year swings in Depreciation and Depletion: crashed 75.0% in 2022 and later surged 216.67% in 2024.
  • Tracing ETON's Depreciation and Depletion over 5 years: stood at $23000.0 in 2021, then crashed by 43.48% to $13000.0 in 2022, then decreased by 7.69% to $12000.0 in 2023, then surged by 216.67% to $38000.0 in 2024, then crashed by 55.26% to $17000.0 in 2025.
  • Business Quant data shows Depreciation and Depletion for ETON at $17000.0 in Q4 2025, $8000.0 in Q3 2025, and $4000.0 in Q2 2025.